68 related articles for article (PubMed ID: 23074275)
1. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias.
Grembecka J; Belcher AM; Hartley T; Cierpicki T
J Biol Chem; 2010 Dec; 285(52):40690-8. PubMed ID: 20961854
[TBL] [Abstract][Full Text] [Related]
3. Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.
Li BE; Ernst P
Exp Hematol; 2014 Dec; 42(12):995-1012. PubMed ID: 25264566
[TBL] [Abstract][Full Text] [Related]
4. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia.
Nakamura A; Masuya M; Shinmei M; Tawara I; Nosaka T; Ono R
Blood Adv; 2024 May; 8(9):2193-2206. PubMed ID: 38452334
[TBL] [Abstract][Full Text] [Related]
5. The PHD fingers of MLL block MLL fusion protein-mediated transformation.
Muntean AG; Giannola D; Udager AM; Hess JL
Blood; 2008 Dec; 112(12):4690-3. PubMed ID: 18796627
[TBL] [Abstract][Full Text] [Related]
6. Myeloid transformation by
Wesolowski R; Kowenz-Leutz E; Zimmermann K; Dörr D; Hofstätter M; Slany RK; Mildner A; Leutz A
Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33144337
[TBL] [Abstract][Full Text] [Related]
7. The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.
Wong SH; Goode DL; Iwasaki M; Wei MC; Kuo HP; Zhu L; Schneidawind D; Duque-Afonso J; Weng Z; Cleary ML
Cancer Cell; 2015 Aug; 28(2):198-209. PubMed ID: 26190263
[TBL] [Abstract][Full Text] [Related]
8. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
Elife; 2021 Aug; 10():. PubMed ID: 34431785
[TBL] [Abstract][Full Text] [Related]
9. MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia.
Itskovich SS; Gurunathan A; Clark J; Burwinkel M; Wunderlich M; Berger MR; Kulkarni A; Chetal K; Venkatasubramanian M; Salomonis N; Kumar AR; Lee LH
Nat Commun; 2020 May; 11(1):2369. PubMed ID: 32398749
[TBL] [Abstract][Full Text] [Related]
10. A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia.
Jassinskaja M; Ghosh S; Watral J; Davoudi M; Claesson Stern M; Daher U; Eldeeb M; Zhang Q; Bryder D; Hansson J
Leukemia; 2024 May; 38(5):1115-1130. PubMed ID: 38555405
[TBL] [Abstract][Full Text] [Related]
11. MLL-ENL cooperates with SCF to transform primary avian multipotent cells.
Schulte CE; von Lindern M; Steinlein P; Beug H; Wiedemann LM
EMBO J; 2002 Aug; 21(16):4297-306. PubMed ID: 12169632
[TBL] [Abstract][Full Text] [Related]
12. HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways.
Miyamoto R; Kanai A; Okuda H; Komata Y; Takahashi S; Matsui H; Inaba T; Yokoyama A
Elife; 2021 Jul; 10():. PubMed ID: 34310280
[TBL] [Abstract][Full Text] [Related]
13. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis.
Yu BD; Hanson RD; Hess JL; Horning SE; Korsmeyer SJ
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10632-6. PubMed ID: 9724755
[TBL] [Abstract][Full Text] [Related]
14. Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL).
Borkin D; Pollock J; Kempinska K; Purohit T; Li X; Wen B; Zhao T; Miao H; Shukla S; He M; Sun D; Cierpicki T; Grembecka J
J Med Chem; 2016 Feb; 59(3):892-913. PubMed ID: 26744767
[TBL] [Abstract][Full Text] [Related]
15. Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.
Howard GC; Wang J; Rose KL; Jones C; Patel P; Tsui T; Florian AC; Vlach L; Lorey SL; Grieb BC; Smith BN; Slota MJ; Reynolds EM; Goswami S; Savona MR; Mason FM; Lee T; Fesik S; Liu Q; Tansey WP
Elife; 2024 Apr; 12():. PubMed ID: 38682900
[TBL] [Abstract][Full Text] [Related]
16. MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.
Crump NT; Smith AL; Godfrey L; Dopico-Fernandez AM; Denny N; Harman JR; Hamley JC; Jackson NE; Chahrour C; Riva S; Rice S; Kim J; Basrur V; Fermin D; Elenitoba-Johnson K; Roeder RG; Allis CD; Roberts I; Roy A; Geng H; Davies JOJ; Milne TA
Nat Commun; 2023 Aug; 14(1):5208. PubMed ID: 37626123
[TBL] [Abstract][Full Text] [Related]
17. STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia.
Mangolini M; de Boer J; Walf-Vorderwülbecke V; Pieters R; den Boer ML; Williams O
Blood; 2013 Jul; 122(4):542-9. PubMed ID: 23741012
[TBL] [Abstract][Full Text] [Related]
18. To stay in shape and keep moving: MLL emerges as a new transcriptional regulator of Rho GTPases.
Chinchole A; Gupta S; Tyagi S
Small GTPases; 2023 Dec; 14(1):55-62. PubMed ID: 37671980
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of
Nam SE; Ko YS; Park KS; Jin T; Yoo YB; Yang JH; Kim WY; Han HS; Lim SD; Lee SE; Kim WS
Ann Surg Treat Res; 2022 Aug; 103(2):63-71. PubMed ID: 36017142
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.
Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B
Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
